These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12964120)

  • 1. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.
    Walling DM; Flaitz CM; Nichols CM
    J Infect Dis; 2003 Sep; 188(6):883-90. PubMed ID: 12964120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia.
    Walling DM; Etienne W; Ray AJ; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):387-95. PubMed ID: 15216477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
    Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
    J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia.
    Walling DM; Flaitz CM; Hosein FG; Montes-Walters M; Nichols CM
    J Infect Dis; 2004 May; 189(9):1656-63. PubMed ID: 15116302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.
    Walling DM; Ling PD; Gordadze AV; Montes-Walters M; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):396-9. PubMed ID: 15216478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EBV replication and therapy of oral hairy leukoplakia using acyclovir].
    Näher H; Helfrich S; Hartmann M; Freese UK
    Hautarzt; 1990 Dec; 41(12):680-2. PubMed ID: 1965185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral hairy leukoplakia: an Epstein-Barr virus-associated disease of patients with HIV.
    Walling DM
    Res Initiat Treat Action; 2000 Dec; 6(4):10-5. PubMed ID: 11708168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.
    Webster-Cyriaque J; Raab-Traub N
    Virology; 1998 Aug; 248(1):53-65. PubMed ID: 9705255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection fighters. High-dose Valtrex for oral hairy leukoplakia.
    TreatmentUpdate; 2003; 15(7):6-7. PubMed ID: 17216869
    [No Abstract]   [Full Text] [Related]  

  • 10. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.
    Höllsberg P; Kusk M; Bech E; Hansen HJ; Jakobsen J; Haahr S
    Acta Neurol Scand; 2005 Dec; 112(6):395-402. PubMed ID: 16281923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infections: prospects for treatment.
    Gershburg E; Pagano JS
    J Antimicrob Chemother; 2005 Aug; 56(2):277-81. PubMed ID: 16006448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy.
    Sunde PT; Olsen I; Enersen M; Grinde B
    J Clin Virol; 2008 Jun; 42(2):176-8. PubMed ID: 18304869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virologic pilot study of valacyclovir in infectious mononucleosis.
    Balfour HH; Hokanson KM; Schacherer RM; Fietzer CM; Schmeling DO; Holman CJ; Vezina HE; Brundage RC
    J Clin Virol; 2007 May; 39(1):16-21. PubMed ID: 17369082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia.
    Walling DM; Clark NM; Markovitz DM; Frank TS; Braun DK; Eisenberg E; Krutchkoff DJ; Felix DH; Raab-Traub N
    J Infect Dis; 1995 May; 171(5):1122-30. PubMed ID: 7751686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of valacyclovir in cats infected with feline herpesvirus 1.
    Nasisse MP; Dorman DC; Jamison KC; Weigler BJ; Hawkins EC; Stevens JB
    Am J Vet Res; 1997 Oct; 58(10):1141-4. PubMed ID: 9328668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy in children with hydroa vacciniforme.
    Lysell J; Wiegleb Edström D; Linde A; Carlsson G; Malmros-Svennilson J; Westermark A; Andersson J; Wahlgren CF
    Acta Derm Venereol; 2009; 89(4):393-7. PubMed ID: 19688153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
    Webster-Cyriaque J; Middeldorp J; Raab-Traub N
    J Virol; 2000 Aug; 74(16):7610-8. PubMed ID: 10906215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.